Cancer is a disease should be treated at single cell level, to that end, the immune system seems to be able to do it. That is what I can advise my graduate students at the beginning of 2024.

Immune checkpoint inhibitors have been transformative for many patients with #lungcancer, but acquired resistance remains a challenge. A study by Danish Memon, Adam J. Schoenfeld, & team found molecular features that may guide the development of new therapies. bit.ly/41SU6W9

ASCO #GU24 Abstract #458 Poster J19-Saturday 7:00am check out our preclinical work spearheaded by Michelle Hsu, PhD(c) on the superiority of a novel #PDL1 inhibitor compared to FDA-approved ICIs in #kidneycancer Mayo Clinic Urology. meetings.asco.org/abstracts-pres…

Tomorrow ASCO #GU24 Michelle Hsu presents Preclinical Testing of a Novel PD-L1 Inhibitor for the Treatment of Renal Cell Carcinoma. Saturday, 7am PST Poster J19 #KidneyCancer Fabrice Lucien, PhD Haidong Dong Joanina Gicobi, Ph.D. (She/Her) Reza Nabavizadeh, MD Rodrigo Pessoa Vidit Sharma R. Houston Thompson B.C. Leibovich MD

Today, we approved the first cellular therapy indicated for treatment of adult patients with a type of skin cancer that is unable to be removed with surgery or has spread to other parts of the body that have previously been treated with other therapies. fda.gov/news-events/pr…

Mayo Clinic in Rochester has received the No. 1 ranking on Newsweek's 'World's Best Hospitals' list for the sixth consecutive year. Gianrico Farrugia, Mayo Clinic president and CEO, credits dedicated staff. mayocl.in/3Tfdutv

Congratulations to our very own Dr. Steven Rosenberg from Surgery Branch for receiving the AACR Lifetime Achievement Award for his fundamental contributions to #CancerResearch! National Cancer Institute

Congrats to Dr. Steve Rosenberg who was awarded #AACR24 Lifetime Achievement Award (intro by Dr. Vonderheide). SO after his lecture. Decades of inquiry to harness the power of T cells to improve the lives patients with melanoma + other cancers Penn Medicine Penn Medicine - Abramson Cancer Center #melanoma

#CART to attack tumor and microenvironment via PD-L1. Find out more Yaqing Qie #AACR24 eppro01.ativ.me/appinfo.php?pa… #AACR24 Dr. Alfredo Quiñones-Hinojosa Dr. Hong Qin Mayo Clinic Comprehensive Cancer Center

How many functional clusters of monocytes are there? How do they impact #CART in #lymsm? Visit Andre Corraes poster today eppro01.ativ.me/appinfo.php?pa… #AACR24 Haidong Dong Mayo Clinic Comprehensive Cancer Center

What is key PD-1 signaling regulation to improve cytotoxic and memory T cell function? Ask Zhiming Mao at poster today eppro01.ativ.me/appinfo.php?pa… #AACR24 Haidong Dong Mayo Clinic Comprehensive Cancer Center

Please join The Journal of Immunology EIC with tips on How to Be the Reviewer You Want to Have! plus tips on image forensics 🧐🧐🧐

never compare yourself with others

According to the CDC, adults who sleep fewer than seven hours each night are more likely to experience health problems. Adequate sleep is crucial for your overall well-being, including your heart health. Learn more: mayocl.in/3V7iCAQ

Big news—a large clinical trial found pembrolizumab after surgery helped people with kidney cancer live longer than those who got a placebo. It's the 1st adjuvant treatment to improve survival after surgery for #KidneyCancer. go.nih.gov/uknCqvH #WorldKidneyCancerDay24

Impressive results from the Rosenberg lab NCI Center for Cancer Research using TCR gene therapy targeting private neoantigens in patients with metastatic colorectal cancer. Tumor regression in majority of patients, including 3/7 (43%) objective responses. nature.com/articles/s4159…

Friday, Nov 22nd at #AIC2024 will feature a meet the speakers roundtable for grad students and postdocs and our keynote address from Donna Farber! Meet the speakers is a popular event, so register early!

Our 2nd edition is in both hard copy and ebook, published in July 2024, 6 years after 1st edition.

Online Now: Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells dlvr.it/TCjSGV

Learn from Mayo Clinic experts how the power of the body's immune system may be harnessed to fight cancer. Join @YILinMDPhD and Hong Qin, M.D., Ph.D., at the Mayo Clinic RegenBio Summit 24, Dec. 9-11 in Ponte Vedra Beach, Florida. Register here: mayocl.in/4e9wxgD